Bhaskar Sambasivan
See the following -
TransCelerate Selects Cognizant To Develop A Clinical Trials Collaboration Platform
Press Release |
TransCelerate BioPharma Inc., Cognizant |
July 24, 2014
Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials...
- Login to post comments